Cassava Sciences | PTIE - Ebit

Prezzo Delle Azioni
1.18
Cambio Giornaliero
-0.06 -4.84%
Mensile
-32.95%
Annuale
-43.54%
Q2 Previsione
1.16




Ebit Cambiamento Data
Abbott USD 1.85B 684M 2026-03
Amgen USD 3.83B 130M 2026-03
Biogen USD 514.3M 502.8M 2026-03
Cara Therapeutics USD -5.94M 3.55M 2025-09
Cassava Sciences USD -13.55M 1.69M 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Geron USD -236K 10.55M 2026-03
J&J USD 6.62B 1.51B 2026-03
Merck USD -1.88B 8.12B 2026-03
Novartis USD 4.18B 118M 2026-03
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 4.99B 340M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12